CapsoVision Inc CV
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
CapsoVision to Present at the 20th Annual LD Micro Main Event
-
CapsoVision Announces FDA Clearance of AI Highlights for CapsoCam Plus®
-
CapsoVision to Participate in Upcoming Investor Conferences
-
CapsoVision Reports Second Quarter 2026 Financial Results
-
CapsoVision® Announces International Launch of AI Highlights
-
CapsoVision to Release Second Quarter 2026 Financial Results on August 13, 2026
-
Visteon Announces Second Quarter 2026 Financial Results and $200 Million Accelerated Share Repurchase Program
-
These 16 stocks are a short seller's dream - likely losers no matter what the market does
Trading Information
- Previous Close Price
- $6.45
- Day Range
- $6.40–6.65
- 52-Week Range
- $4.50–15.37
- Bid/Ask
- $5.90 / $6.82
- Shares Outstanding
- 53.21M
- Market Cap
- $347.46M
- Volume/Avg
- 160,778 / 156,714
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 8.01
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
CapsoVision Inc is a commercial-stage medical technology enterprise that innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system. The company's core technology platform is an orally ingestible capsule including multiple cameras facilitating 360-degree imaging, light-emitting diodes for measurement, onboard memory storage, and battery life permitting recording and onboard storage of video images. CapsoVision's products consist of the on-market CapsoCam Plus, directed at the small intestines, and the in-development CapsoColon 3D, directed at the large intestines. Geographically, the company generates the majority of its revenue from the United States.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 99
- Website
- https://www.capsovision.com
Valuation
|
Metric
|
CV
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 24.81 |
Price/Sales | 8.01 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
CV
|
|---|---|
Quick Ratio | 2.20 |
Current Ratio | 3.35 |
Interest Coverage | — |
Quick Ratio
CV
Profitability
|
Metric
|
CV
|
|---|---|
Return on Assets (Normalized) | −146.65% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
CV
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|CD>W$P | LOCK|#qQl | $181B | |||
| Medtronic PLC
MDT
| LOCK|VS!!z@ | LOCK|!JXp | $121B | |||
| Stryker Corp
SYK
| LOCK|b?z>Kbw | LOCK|#n | $113B | |||
| Boston Scientific Corp
BSX
| LOCK|&rHy&TZ | LOCK|sV&^! | $64B | |||
| Edwards Lifesciences Corp
EW
| LOCK|&TZ#RXq | LOCK|SJlt^ | $50B | |||
| DexCom Inc
DXCM
| LOCK|n>YMlg^ | LOCK|TVx@k | $32B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|cQxz?# | LOCK|FfT | $31B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|^R | LOCK|>< | $25B | |||
| Steris PLC
STE
| LOCK|%cPjyk | LOCK|@dL?^ | $22B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|d#Lb%j&r | LOCK|%!L | $18B |
United States